Device Trial Radar · NCT00562302
Bio-Seal Biopsy Track Plug for Reducing Pneumothorax Rates Post Lung Biopsy Procedure
Last checked: Nov 20, 2026Latest source record: Mar 27, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
339
Actual
Start
Apr 2005
Primary completion
Jun 2008
Study completion Aug 2008
Sponsor
- Lead sponsor
- Angiotech PharmaceuticalsNot on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 22, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
BS-1053 A Prospective Randomized Multi-Centered Safety and Efficacy Evaluation of the Bio-Seal Biopsy Track Plug for Reducing Pneumothorax Rates Post Lung Biopsy Procedures
Conditions
- Pneumothorax
Interventions
Bio-Seal PlugDevice
Deployment of the Bio-Seal plug in needle track
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence Rate of Treatment SuccessTime frame: 30 days
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Scottsdale Medical Imaging
Scottsdale, Arizona
St. Josephs Radiology Limited
Tuscon, Arizona
UCLA School of Medicine
Los Angeles, California
15 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.